Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (121-130 of 350) with videos related to

Pageof 35
Sort By:
Hematologic Pathology|January 1, 1988
Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemiaS O'Brien, H Kantarjian, M Shtalrid, et al.
British Journal of Haematology|September 1, 1986
Chronic myelogenous leukaemia: haematological remissions with alpha interferonM Talpaz, K McCredie, H Kantarjian, et al.
Annals of Hematology|December 1, 1993
Growth factors controlling interleukin-4 action on hematopoietic progenitorsA Ferrajoli, T F Zipf, M Talpaz, et al.
Cancer Research|May 1, 1993
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptomsR Kurzrock, J Redman, F Cabanillas, et al.
Leukemia & Lymphoma|May 9, 2001
Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemiaN M Tannir, M Talpaz, H Ghazal, et al.
JAMA|April 22, 1992
Myelokathexis: normalization of neutrophil counts and morphology by GM-CSFM Wetzler, M Talpaz, M J Kellagher, et al.
Blood|March 1, 1987
Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemiaG Yoffe, M Blick, H Kantarjian, et al.
Oncogene|January 1, 1989
Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemiaP Romero, M Beran, M Shtalrid, et al.
Blood|November 1, 1987
Expression of c-abl in Philadelphia-positive acute myelogenous leukemiaR Kurzrock, M Shtalrid, M Talpaz, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine therapy in chronic lymphocytic leukemia (CLL)M J Keating, H Kantarjian, M Talpaz, et al.
Pageof 35

Showing results (121-130 of 350) with videos related to

Sort By:
Pageof 35
Hematologic Pathology|January 1, 1988
Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome-positive chronic myelogenous leukemiaS O'Brien, H Kantarjian, M Shtalrid, et al.
British Journal of Haematology|September 1, 1986
Chronic myelogenous leukaemia: haematological remissions with alpha interferonM Talpaz, K McCredie, H Kantarjian, et al.
Annals of Hematology|December 1, 1993
Growth factors controlling interleukin-4 action on hematopoietic progenitorsA Ferrajoli, T F Zipf, M Talpaz, et al.
Cancer Research|May 1, 1993
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptomsR Kurzrock, J Redman, F Cabanillas, et al.
Leukemia & Lymphoma|May 9, 2001
Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemiaN M Tannir, M Talpaz, H Ghazal, et al.
JAMA|April 22, 1992
Myelokathexis: normalization of neutrophil counts and morphology by GM-CSFM Wetzler, M Talpaz, M J Kellagher, et al.
Blood|March 1, 1987
Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemiaG Yoffe, M Blick, H Kantarjian, et al.
Oncogene|January 1, 1989
Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemiaP Romero, M Beran, M Shtalrid, et al.
Blood|November 1, 1987
Expression of c-abl in Philadelphia-positive acute myelogenous leukemiaR Kurzrock, M Shtalrid, M Talpaz, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Fludarabine therapy in chronic lymphocytic leukemia (CLL)M J Keating, H Kantarjian, M Talpaz, et al.
Pageof 35